Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the O ne M illion T aiwanese S creening P rogram

Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program

BACKGROUND The effectiveness of fecal immunochemical testing (FIT) in reducing colorectal cancer (CRC) mortality has not yet been fully assessed in a large, population-based service screening program. METHODS A prospective cohort study of the follow-up of approximately 5 million Taiwanese from 2004 to 2009 was conducted to compare CRC mortality for an exposed (screened) group and an unexposed...

The effectiveness of colonoscopy in reducing mortality from colorectal cancer.

S E R U M Levels of Second C O M P O N E N T of C O M P L E M E N T in Cancer P a T I E N T S 1

Awareness that advancing cancer is often accompanied by defective imnmnologic responses, and accumulating evidence that immune reactions may influenee the course of cancer, has stimulated the study of various meehanisms of immunologic reaction in patients with cancer. As part of such a program we have determined the serum level of the second component of complement in a group of cancer patients...

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening

BACKGROUND The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is considering switching from biennial guaiac fecal occult blood test (gFOBT) screening between age 50-74 years to the more sensitive, but also less specific fecal immunochemical test (FIT). The aim of this study is to estimate whether the additional benefits of FIT screening compared to gFOBT outw...

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

BACKGROUND Although tests for occult blood in the feces are widely used to screen for colorectal cancers, there is no conclusive evidence that they reduce mortality from this cause. We evaluated a fecal occult-blood test in a randomized trial and documented its effectiveness. METHODS We randomly assigned 46,551 participants 50 to 80 years of age to screening for colorectal cancer once a year,...